Ibaraki, Japan

Kenzo Bamba

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Humantec Ltd., Lymphotec Inc., Other. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenzo Bamba. Retrieved from https://idiyas.com/inventor/kenzo-bamba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tokyo, JP (2003)
  • Ibaraki, JP (2004 - 2013)

Company Filing History:


Years Active: 2003-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kenzo Bamba: Innovator in Hematopoietic Stem Cell Research

Introduction

Kenzo Bamba is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of hematopoietic stem cell research, holding a total of 3 patents. His work focuses on methods that enhance the survival and efficacy of transplanted stem cells, which is crucial for various medical therapies.

Latest Patents

One of Kenzo Bamba's latest patents is a method for producing a composition that promotes the survival of transplanted hematopoietic stem cells. This innovative approach involves the proliferation and activation of HLA matched lymphocytes from mononuclear cells separated from peripheral blood or umbilical cord blood. The resulting composition is designed to prevent survival failure of transplanted hematopoietic stem cells and to promote their survival in patients. The administration of this composition can vary based on the patient's age and condition, with a recommended dosage of a humanized antibody ranging from 0.2 to 20 ml/kg/day. The composition can be administered intravenously either as a single daily dose or intermittently.

Another significant patent involves the use of cord blood-derived activated lymphocytes, which have shown effectiveness in preventing and treating various tumors and infections. This method includes the preparation of lymphocytes derived from cord blood, which can be proliferated in vitro with interleukin 2 and/or anti-CD3 antibody. These activated lymphocytes are also beneficial for preventing disease recurrence and promoting the acceptance of stem cells or other organs.

Career Highlights

Kenzo Bamba has worked with several companies, including Humantec Ltd. and Lymphotec Inc. His experience in these organizations has contributed to his expertise in the field of stem cell research and therapy.

Collaborations

Kenzo has collaborated with notable individuals in his field, including Yasuyuki Kuroiwa and Teruaki Sekine. These partnerships have likely enhanced his research and development efforts.

Conclusion

Kenzo Bamba is a prominent inventor whose work in hematopoietic stem cell research has the potential to significantly impact medical therapies. His innovative patents and collaborations reflect his commitment to advancing this critical area of science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…